Ranbaxy's Provigil gets tentative FDA approval
By siliconindia staff writer
|
Friday, 20 February 2004, 20:30 IST
MUMBAI: Ranbaxy Laboratories has got tentative approval for Modafinil tablets, a generic form of nacrolepsy drug Provigil, the US Food and Drug Administration (FDA) said late on Thursday.
Provigil, the flagship drug of Cephalon Inc, is prescribed for a rare disorder marked by uncontrollable sleep during normal waking hours.
No other details were immediately available.